Cromwell Holdings »

Vertex Pharmaceuticals Incorporated shares owned by Cromwell Holdings

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cromwell Holdings from 13F filings

Historical chart of Cromwell Holdings investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cromwell Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cromwell Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $260k 663 391.64
2025-06-30 $292k 656 445.20
2025-03-31 $310k 640 484.82
2024-12-31 $318k 789 402.70
2024-09-30 $386k 830 465.08
2024-06-30 $372k 794 468.72

More positions owned by Cromwell Holdings

NVIDIA Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
iShares Trust CORE S&P500 ETF Etf (IVV)
Meta Platforms Inc CL A Class A Shares (META)
Broadcom Common Stock (AVGO)
Alphabet Inc. CAP STK CL A Class A Shares (GOOGL)
Alphabet Inc. CAP STK CL C Common Stock (GOOG)
Tesla Common Stock (TSLA)
JPMorgan Chase & Co Common Stock (JPM)
Berkshire Hathaway Inc. CL B Common Stock (BRK.B)
Vanguard Index Funds TOTAL STK MKT Common Stock (VTI)
Eli Lilly & Co Common Stock (LLY)
Visa Inc COM CL A Class A Shares (V)

View all positions for Cromwell Holdings

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated